Modular Medical

Executive Summary

Modular Medical, a San Diego-based medical device company founded in 2015, is developing the MODD1 insulin pump to simplify diabetes management. The MODD1 is designed as a user-friendly alternative to traditional pumps and multiple daily injections, focusing on ease of use and seamless data sharing with care teams. The company aims to expand access to insulin pump therapy by reducing complexity, addressing a significant unmet need in the diabetes market. With its innovative approach, Modular Medical has the potential to capture share in the insulin pump segment, which is growing due to increasing diabetes prevalence and patient preference for automated therapy. However, as a private company still in development, execution risks remain, including regulatory clearance and commercial adoption.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) Submission for MODD1 Pump60% success
• Q1 2027Presentation of Clinical Study Data75% success
• Q2 2027Commercial Launch or Strategic Partnership50% success